Patent · US Active

Heterocyclic compounds useful for kinase inhibition

US10214513B2 · kind B2 · utility

0Cited by
38References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2015
Grant dateFeb 26, 2019
Priority date—
Expiry dateDec 10, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/48
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds useful for kinase inhibition.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.